Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Oncogene

TABLE 23-15 Some Oncogenes Found in Human Tumors  [Pg.780]

N-ras mutation Signal transduction Guanine diphosphate (GDP)/ guanine triphosphate (GTP) binding protein Acute myeloid leukemia, neuroblastoma [Pg.780]

K-rfls mutation Signal transduction GDP/GTP binding protein Leukemia, lymphoma [Pg.780]

The c-myc gene is the proto-oncogene of avian myelocytoma virus. It binds to DNA and is involved in transcription regulation. The gene product, p62, is located in the nucleus of transformed cells, and levels of c-myc correlate with the rate of cell division. The c-myc protein is essential for DNA replication and enhances mRNA transcription. Activation of the c-myc gene is associated with B- and T-ceH lymphoma, sarcomas, and endotheliomas. In leukemias and lymphomas, increased c-myc expression may be due to amplification or chromosomal translocation of the gene. In acute T-celi leukemias, there is an (8 14) (q24 qll) translocation that [Pg.781]

The HER-2/new gene (also known as c-erbB-2) is named for its association with neural tumors (new). [Pg.781]

The cellular form of oncogenes (known as c-oncogenes or proto-oncogenes) code for proteins involved in controlling growth and differentiation processes. They only become oncogenes if their sequence has been altered by mutations (see p. 256), deletions, and other processes, or when excessive amounts of the gene products have been produced as a result of overexpression. [Pg.398]

A feature common to all oncogenes is the fact that they code for proteins involved in signal transduction processes. The genes are designated using three-letter abbreviations that [Pg.398]

Ligands such as growth factors and cytokines, which promote cell proliferation. [Pg.398]

Membrane receptors of the 1-helix type with tyrosine kinase activity, which can bind growth factors and hormones (see p. 394). [Pg.398]

GTP-binding proteins. This group includes the G proteins in the strict sense and related proteins such as Ras (see p. 388), the product of the oncogene c-ras. [Pg.398]

Evidence for the first oncogene was found when certain mutants of RSV failed to transform cells at high temperature but did transform cells at low temperature. The mutant virus replicated well at both temperatures. This means that the virus contained a tem-perature-sensitive mutation in a gene that coded for a sarcoma-producing protein, that is, for v-src. [Pg.244]

Normal cells also were found to contain src-like genes when their DNA was hybridized with labeled nucleic acid probes from the v-src gene. As with other cellular genes, the c-onc genes were interrupted with introns. v-Onc genes lack introns. Consequently, in the distant past c-onc genes must have been transferred to the retroviruses. If the transfer had been from the virus to the cell, c-onc genes probably would not contain introns. [Pg.244]

The oncogene v-erbB, unlike c-erbB, codes for a shortened form of the EGF receptor protein. Usually the binding of EGF is required to turn on the tyrosine kinase activity of the EGF receptor protein, the one coded by c-erbB. However, the tyrosine kinase activity of the receptor derived from v-erbB is switched on permanently, even in the absence of EGF. The uncontrolled grqwth characteristic of cancer cells results. [Pg.244]

Other oncogenes code for proteins that bind guanine nucleotides, and others code for nuclear proteins. The guanine nucleotide-binding proteins, the so-called G proteins, affect several key reactions. Some G proteins are stimulatory, whereas others are inhibitory. For example, they link hormone receptors to adenylate cyclase, they translocate [Pg.244]

TABLE 9.4 EXAMPLES OF PROMOTERS WITH THEIR ASSOCIATED NEOPLASMS IN HUMANS.  [Pg.245]

The EIA protein of adenovirus binds to and inactivates the product of the retinoblastoma (RB) gene — an antioncogene. The RB protein in some way acts to control cell proliferation and its inactivation has been implicated in a number of different human tumours (White et al., 1988 Weinberg, 1988). [Pg.31]

Tumourogenicity can also be induced by overproduction and mutation of the p53 protein which appears to be an antioncogene product similar to that of the RB gene (Finlay et al., 1989). The altered p53 protein binds tightly to the transforming proteins of [Pg.31]

SV40 and adenovirus and this may indicate how they exert their effect (Eliyahu et al., 1985 Lane, 1984 Wang et al., 1989). [Pg.32]

At this point, there is an interaction with a very important 21-kDa protein. This protein, called p21 or just Ras, is involved in about 30% of human tumors. The designation Ras comes from Rat sarcoma, the original tissue in which it was discovered. The Ras family of proteins are GTP-binding [Pg.427]

A Representative List of Proto-Oncogenes Implicated in Human Tumors  [Pg.427]

Adapted from Bishop, J. M. 1991, Molecular themes in oncogenesis. Cell64.235-248. [Pg.427]


Eadier reports of a link between testicular cancer and DMF exposure have not been corroborated ia a study of 4000 Du Pont employees (34). Very recendy, inhalation studies ia mice and rats have shown no oncogenic effect from DMF (35). The International Agency for Research on Cancer (lARC) has concluded that evidence associating DMF with cancer ia animals is "iaadequate," but has classified DMF as "possibly carciaogenic to humans" (Group 2B) (36). [Pg.515]

Many human diseases are caused when certain proteins are either over- or underexpressed. Eor example, breast cancer can be induced by overexpressing certain cellular oncogenes within mammary tissue. To study the disease, researchers produce a line of transgenic mice that synthesize an abnormal amount of the same protein. This leads to symptoms of the disease in mice that are similar to what is found in humans. A protein can be overexpressed by inserting a DNA constmct with a strong promotor. Conversely, underexpression of a protein can be achieved by inserting a DNA constmct that makes antisense RNA. This latter blocks protein synthesis because the antisense RNA binds and inactivates the sense mRNA that codes for the protein. Once a line of mice is developed, treatments are studied in mice before these therapies are appHed to humans. [Pg.242]

J. M. Smith and co-workers, "Methyl Methacrylate Subchronic, Chronic and Oncogenic Inhalation Safety Evaluation Studies," Mbstracts of the Eighteenth Mnnual Meeting of the Society of Toxicology, New Orleans, La., 1979. [Pg.257]

The relationship between the two receptors for NGF is complex and not yet completely understood. It has been suggested that the functional form of the NGF receptor is a heterodimer of p75 and pl40 proteins. BDNF and NT-3 bind to p75, but the functional receptors for these neurotrophins are the proto-oncogene products of and trkQ. [Pg.563]

The streptovaricins inhibit the reverse transcriptase of some RNA oncogenic vimses that may be involved in the process of viral transformation (see Antiviral agents). The atropisostreptovaricins again have similar activities to the corresponding natural isomers. The streptovals and streptovarone exhibit gready improved activity against reverse transcriptase relative to the streptovaricins (85), but their in vitro activities were low (86). The damavaricins also inhibit reverse transcriptase (4) as well as tumor cell growth (87). [Pg.495]

Biotechnology. Particular attention must be paid to the detection of DNA in all finished biotechnology products because of the possibiUty that such DNA could be incorporated into the human genome and thus become a potential oncogene. The absence of DNA at the picogram-per-dose level should be demonstrated in order to assure the safety of biotechnology products (157). [Pg.251]

Retroviridae Types B and C Oncovirus numerous leukemias, including friend. oncogenic of lower animals... [Pg.303]

Gross Moloney, Rauscher rous sarcoma, HIV oncogenic of fowl, aids... [Pg.303]

The leucine zipper motif (see Chapter 3) was first recognized in the amino acid sequences of a yeast transcription factor GCN4, the mammalian transcription factor C/EBP, and three oncogene products, Fos, Jun and Myc, which also act as transcription factors. When the sequences of these proteins are plotted on a helical wheel, a remarkable pattern of leucine residues... [Pg.191]

Jumak, F. Structure of the GDP domain of EF-Tu and location of the amino acids homologous to ras oncogene proteins. Science 230 32-36, 1985. [Pg.280]

Pai, E.F., et al. Structure of the guanine-nucleotide-binding domain of the Ha-ras oncogene product p21 in the triphosphate conformation. Nature 341 209-214,... [Pg.281]

Scheffzek, K., et al. The Ras-RasGAP complex structural basis for GTPase activation and its loss in oncogenic Ras mutants. Science 277 333-338, 1997. [Pg.281]

Some occupational hygiene aspects of man-made mineral fibres and new technology fibres Safe handling requirements dunng explosive, propellant and pyrotechnic manufacture Simplified calculations of blast induced injuries and damage Laboratory work with chemical carcinogens and oncogenes Rosin (colophony) a review... [Pg.584]

TABLE 5.22 Important Oncogenes and Tumor Suppressor Genes in Human Cancers... [Pg.319]

Woodget, J. R., 1991. A common denominator linking glycogen metabolism, nuclear oncogenes, and development. Trends in Biochemical Sciences 16 177-181. [Pg.774]

Thiophene, 2,2-bithiophene, and 2,2, 5, 2"-terthiophene derivatives from Chinese medicinal plants as oncogene signal transduction inhibitors (proteinki-nase C inhibitors) 99PAC1101. [Pg.236]

Ravichandran KS (2001) Signaling via She family adapter proteins. Oncogene 20 6322-6330... [Pg.19]


See other pages where Oncogene is mentioned: [Pg.45]    [Pg.158]    [Pg.202]    [Pg.563]    [Pg.146]    [Pg.146]    [Pg.147]    [Pg.147]    [Pg.147]    [Pg.148]    [Pg.149]    [Pg.263]    [Pg.279]    [Pg.283]    [Pg.113]    [Pg.212]    [Pg.488]    [Pg.497]    [Pg.118]    [Pg.235]    [Pg.433]    [Pg.179]    [Pg.192]    [Pg.199]    [Pg.199]    [Pg.251]    [Pg.261]    [Pg.279]    [Pg.280]    [Pg.318]    [Pg.319]    [Pg.343]    [Pg.276]    [Pg.406]   
See also in sourсe #XX -- [ Pg.1278 , Pg.1279 ]

See also in sourсe #XX -- [ Pg.18 , Pg.21 , Pg.159 , Pg.225 , Pg.237 ]

See also in sourсe #XX -- [ Pg.620 ]

See also in sourсe #XX -- [ Pg.342 ]

See also in sourсe #XX -- [ Pg.487 ]

See also in sourсe #XX -- [ Pg.399 , Pg.400 ]

See also in sourсe #XX -- [ Pg.131 ]

See also in sourсe #XX -- [ Pg.210 , Pg.212 ]

See also in sourсe #XX -- [ Pg.96 , Pg.99 , Pg.151 , Pg.157 ]

See also in sourсe #XX -- [ Pg.179 ]

See also in sourсe #XX -- [ Pg.95 ]

See also in sourсe #XX -- [ Pg.36 ]

See also in sourсe #XX -- [ Pg.277 ]

See also in sourсe #XX -- [ Pg.242 , Pg.544 , Pg.571 , Pg.572 , Pg.573 , Pg.574 , Pg.575 ]

See also in sourсe #XX -- [ Pg.545 ]

See also in sourсe #XX -- [ Pg.592 , Pg.851 , Pg.853 ]

See also in sourсe #XX -- [ Pg.535 ]

See also in sourсe #XX -- [ Pg.227 , Pg.245 , Pg.246 , Pg.536 ]

See also in sourсe #XX -- [ Pg.29 , Pg.31 ]

See also in sourсe #XX -- [ Pg.376 ]

See also in sourсe #XX -- [ Pg.563 , Pg.565 , Pg.566 , Pg.567 , Pg.568 , Pg.569 , Pg.570 , Pg.571 , Pg.572 , Pg.573 , Pg.574 ]

See also in sourсe #XX -- [ Pg.36 ]

See also in sourсe #XX -- [ Pg.44 , Pg.85 , Pg.171 ]

See also in sourсe #XX -- [ Pg.91 , Pg.187 ]

See also in sourсe #XX -- [ Pg.242 , Pg.544 , Pg.571 , Pg.572 , Pg.573 , Pg.574 , Pg.575 ]

See also in sourсe #XX -- [ Pg.653 ]

See also in sourсe #XX -- [ Pg.3 , Pg.5 , Pg.5 , Pg.21 , Pg.22 , Pg.23 , Pg.24 , Pg.25 ]

See also in sourсe #XX -- [ Pg.45 ]

See also in sourсe #XX -- [ Pg.609 ]

See also in sourсe #XX -- [ Pg.400 ]

See also in sourсe #XX -- [ Pg.2281 , Pg.2282 , Pg.2282 , Pg.2283 , Pg.2283 ]

See also in sourсe #XX -- [ Pg.40 , Pg.372 ]

See also in sourсe #XX -- [ Pg.656 ]

See also in sourсe #XX -- [ Pg.248 ]

See also in sourсe #XX -- [ Pg.16 ]

See also in sourсe #XX -- [ Pg.62 , Pg.67 , Pg.91 , Pg.129 , Pg.403 ]

See also in sourсe #XX -- [ Pg.25 , Pg.545 ]

See also in sourсe #XX -- [ Pg.516 ]

See also in sourсe #XX -- [ Pg.216 ]

See also in sourсe #XX -- [ Pg.38 ]

See also in sourсe #XX -- [ Pg.242 , Pg.544 , Pg.571 , Pg.572 , Pg.573 , Pg.574 , Pg.575 ]

See also in sourсe #XX -- [ Pg.242 , Pg.544 , Pg.571 , Pg.572 , Pg.573 , Pg.574 , Pg.575 ]

See also in sourсe #XX -- [ Pg.216 ]

See also in sourсe #XX -- [ Pg.139 ]

See also in sourсe #XX -- [ Pg.457 ]

See also in sourсe #XX -- [ Pg.582 ]

See also in sourсe #XX -- [ Pg.321 ]

See also in sourсe #XX -- [ Pg.211 , Pg.212 , Pg.213 , Pg.214 , Pg.215 ]

See also in sourсe #XX -- [ Pg.7 ]

See also in sourсe #XX -- [ Pg.50 ]

See also in sourсe #XX -- [ Pg.111 ]

See also in sourсe #XX -- [ Pg.326 ]

See also in sourсe #XX -- [ Pg.127 ]

See also in sourсe #XX -- [ Pg.383 ]




SEARCH



Activated oncogenes

Adenovirus oncogenic

Adenovirus oncogenicity

Adenoviruses, oncogenes

Animal oncogenic viruses

Anti-oncogenes

Anti-oncogenes tumor- suppressor genes

Avian oncogenes

Avian oncogenic virus

BCR-ABL oncogene

Basic Techniques Used in the Study of Oncogenes

Braf oncogene

C-Src proto-oncogene

C-abl oncogene

C-kit proto-oncogene

C-mos proto-oncogene

C-myc oncogene

C-oncogenes

Caenorhabditis activated oncogenes

Cancer biology oncogenes

Cancer oncogene

Cancer oncogenes and

Cancer oncogenicity studies

Cancer proto-oncogene mutation

Cancer proto-oncogenes

Cancer-causing chemicals oncogenes

Causes of Oncogenic Mutations

Cell Transformation proto-oncogenes

Cell proliferation: oncogenes

Cell proliferation: oncogenes regulation

Chronic myelogenous leukemia, oncogenes

Cyclin Oncogenic Activation

DNA Oncogenic Viruses

Disease proto-oncogenes

ERBB2 oncogene

Epidermal growth factor receptor oncogene

ErbB oncogene

Fos oncogene

Genetic mutations oncogenic

Growth Factors, Oncogenes, and the Cell Cycle

Growth factors oncogenes and

Growth-related oncogene

Growth-related oncogene-” (GRO

Her-2 oncogene

Jun oncogene

K-ras oncogene

Ligands oncogenes

Lung cancer oncogenic cell transformation

MDM2 oncogene

Malignancy oncogenes

Markers oncogenes

Methylation oncogene

Myc-oncogene

N-ras-Oncogene

Neoplasms, oncogenicity studie

Neu oncogene

Oncogen

Oncogene Cellular

Oncogene Characterization and Mode of Action

Oncogene Classification

Oncogene Cooperation

Oncogene Function

Oncogene activation

Oncogene addiction

Oncogene effects

Oncogene expression

Oncogene function inhibitor

Oncogene function inhibitor from microbial secondary metabolites

Oncogene function inhibitor screening

Oncogene genetic alteration

Oncogene inhibition

Oncogene product

Oncogene signal inhibitory activity

Oncogene stability

Oncogenes amplification

Oncogenes and

Oncogenes and Tumor Suppressor Genes

Oncogenes and cell signaling

Oncogenes and signal transduction

Oncogenes applications

Oncogenes association with tumor-causing viruses

Oncogenes growth factors expressed

Oncogenes in cancer

Oncogenes in human tumors

Oncogenes in humans

Oncogenes overactivation

Oncogenes signal transduction factors expressed

Oncogenes table

Oncogenes transcription factors

Oncogenes transcription factors expressed

Oncogenes types

Oncogenes, vitamin

Oncogenic

Oncogenic

Oncogenic Ras-driven cancer

Oncogenic cell transformation

Oncogenic fusion oncoproteins, cellular

Oncogenic kinases

Oncogenic mutation

Oncogenic mutation, causes

Oncogenic process

Oncogenic transformation

Oncogenic viral gene products

Oncogenicity

Oncogenicity studies

Oncogenicity studies conduct

Oncogenicity studies dose selection

Oncogenicity studies duration

Oncogenicity studies regulatory requirements

Oncogenicity testing

Oncogenicity testing animal type

Oncogens

Oncogens

Polyoma virus, oncogenes

Primordial Fused Genes Become Oncogenes and Encode Oncoproteins

Prostate tumors oncogenes

Protein kinases oncogenes

Protein oncogenic

Protein tyrosine kinases oncogene studies

Proteins expressed by oncogenes

Proto-oncogen

Proto-oncogene Activation mechanism

Proto-oncogene Function

Proto-oncogene Overexpression

Proto-oncogene c-Myc

Proto-oncogene expression

Proto-oncogene products

Proto-oncogenes

Proto-oncogenes ancestors

Proto-oncogenes classical

Proto-oncogenes generation

Proto-oncogenes, activation

Protooncogene and Oncogene Products

Quantitation oncogene expression

RET proto-oncogene

Raf oncogene

Ras oncogene

Ras oncogene, expression

Receptors oncogenes

Regulation of Cell Proliferation Oncogenes

Ret oncogen

Retroviruses, oncogenes and

Risk assessment oncogenic viruses

Signal transduction oncogenes

Sis-Oncogene

Skin tumors oncogenes

Src oncogene

Suppressor oncogenes

Toxicity testing oncogenicity studies

Transcription factor proto-oncogenes

Transforming Oncogenes

Tumor markers oncogenes

Tumorigenesis, oncogenes and

Tumors proto-oncogenes

V-erbA oncogene

V-erbB oncogene

Viral and cellular oncogenes

Viral oncogenes

Viruses oncogene association with

Viruses oncogenic

© 2024 chempedia.info